Clinical practice guidelines in nephrology: Evaluation, classification, and stratification of chronic kidney disease

被引：72

作者：

Bailie, GR

Uhlig, K

Levey, AS

机构：

[1] Albany Coll Pharm, Dept Pharm Practice, Albany Nephrol Pharm Grp, Albany, NY 12208 USA

[2] Tufts Univ, Sch Med, Div Nephrol, Dept Med, Boston, MA 02111 USA

来源：

PHARMACOTHERAPY | 2005年 / 25卷 / 04期

基金：

美国国家科学基金会; 中国国家自然科学基金;

关键词：

nephrology clinical practice guidelines; chronic kidney disease; CKD; Kidney Disease Outcomes Quality Initiative; K/DOQI; National Kidney Foundation;

D O I：

10.1592/phco.25.4.491.61034

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the evaluation, classification, and stratification of chronic kidney disease (CKD). These guidelines provide, for the first time, a standard definition of CKD, classification of its stages, and suggestions for appropriate laboratory measurements for the assessment of kidney function. Also discussed are the association of level of kidney function with systemic complications that develop during CKD, and the risk of loss of kidney function and development of cardiovascular disease in CKD.

引用

页码：491 / 502

页数：12

共 15 条

[1]

From dialysis outcomes quality initiative to kidney disease outcomes quality initiative: New clinical practice guidelines in nephrology - What the practicing pharmacist needs to know [J].